Search - tctmd.com

Displaying 941 - 960 of 1676

Sort: Relevancy | Date

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Updates From the UK All-Comer TAVR Study

Presenter: Neil E. Moat

June 16, 2016

Presentation TVT 2016

Updates From SURTAVI in Intermediate-Risk Patients

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Presenter: Vinod H. Thourani

June 16, 2016

Presentation TVT 2016

Updates From NOTION: The First All-Comer TAVR Trial

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

Highlights From PARTNER 2A in Intermediate-Risk Patients

Presenter: Michael J. Mack

June 16, 2016

Presentation TVT 2016

The Current Practice of Risk Profiling and Patient Selection for TAVR in the EU: Evidence Based or Common Sense?

Presenter: Antonio Colombo

June 16, 2016

Presentation TVT 2016

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

State-of-the-Art Approach to Reducing Conduction Abnormalities and PVR During TAVR

Presenter: Bernard Prendergast

June 16, 2016

Presentation TVT 2016

The PORTICO TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Ganesh Manoharan

June 16, 2016

Presentation TVT 2016

Imaging Preferences and Hemodynamic Assessments to Determine the Severity of PVR During TAVR: Factors Influencing Treatment Thresholds

Presenter: Didier Tchetche

June 16, 2016

Presentation TVT 2016

TVT 1162: Calcium and the Rising EDP TAVR and Same-Setting PVL Closure

Presenter: Jonathon M. White

June 16, 2016

Presentation TVT 2016

Echo and CT Patterns of Calcification and Annulus Geometry Can Usually Predict PVR During TAVR

Presenter: Omar K. Khalique

June 16, 2016

Presentation TVT 2016

The DIRECT FLOW TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Azeem Latib

June 16, 2016

Presentation TVT 2016

The Clinical Impact of Paravalvular Regurgitation After TAVR

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Achieving the Intended Implant Depth During TAVR: Obstacles and Solutions

Presenter: Nicolo Piazza

June 16, 2016

Presentation TVT 2016

Can CT Imaging Help to Characterize High-Risk Patients for Conduction Disturbances During TAVR?

Presenter: Jonathon A. Leipsic

June 16, 2016

Presentation TVT 2016

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

Presenter: Philippe Généreux

June 16, 2016

Presentation TVT 2016

The EVOLUT R TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: James B. Hermiller Jr

June 16, 2016

Presentation TVT 2016

State-of-the-Art Approach to TAVR in Bicuspid Aortic Valve Disease: From Patient Screening to Device Selection and Procedural Techniques

Presenter: Horst Sievert

June 16, 2016

Advertisement

Study Design for the EVOLUT R Low-Risk Trial

Updates From the UK All-Comer TAVR Study

Updates From SURTAVI in Intermediate-Risk Patients

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Updates From NOTION: The First All-Comer TAVR Trial

Highlights From PARTNER 2A in Intermediate-Risk Patients

The Current Practice of Risk Profiling and Patient Selection for TAVR in the EU: Evidence Based or Common Sense?

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

State-of-the-Art Approach to Reducing Conduction Abnormalities and PVR During TAVR

The PORTICO TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Imaging Preferences and Hemodynamic Assessments to Determine the Severity of PVR During TAVR: Factors Influencing Treatment Thresholds

TVT 1162: Calcium and the Rising EDP TAVR and Same-Setting PVL Closure

Echo and CT Patterns of Calcification and Annulus Geometry Can Usually Predict PVR During TAVR

The DIRECT FLOW TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

The Clinical Impact of Paravalvular Regurgitation After TAVR

Achieving the Intended Implant Depth During TAVR: Obstacles and Solutions

Can CT Imaging Help to Characterize High-Risk Patients for Conduction Disturbances During TAVR?

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

The EVOLUT R TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

State-of-the-Art Approach to TAVR in Bicuspid Aortic Valve Disease: From Patient Screening to Device Selection and Procedural Techniques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content